LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Endara, P; Vaca, M; Chico, M E; Erazo, S; Oviedo, G; Quinzo, I; Rodriguez, A; Lovato, R; Moncayo, A-L; Barreto, M L; Rodrigues, L C; Cooper, P J (2010)
Publisher: Blackwell Publishing Ltd
Journal: Clinical and Experimental Allergy
Languages: English
Types: Article
Subjects: Original Articles: Epidemiology of Allergic Disease, geohelminths, allergen skin reactivity, ivermectin
Background The low prevalence of allergic disease in the rural tropics has been attributed to the protective effects of chronic helminth infections. There is concern that treatment-based control programmes for these parasites may lead to an increase in the prevalence of allergic diseases. Objective We measured the impact of 15–17 years of anthelmintic treatment with ivermectin on the prevalence of allergen skin test reactivity and allergic symptoms in school-age children. Methods The prevalence of allergen skin test reactivity, exercise-induced bronchospasm and allergic symptoms was compared between school-age children living in communities that had received community-based treatments with ivermectin (for onchocerciasis control) for a period of 15–17 years with those living in geographically adjacent communities that had received no ivermectin. Results The prevalence of allergen skin test reactivity was double in children living in treated communities compared with those in untreated communities (16.7% vs. 8.7%, adjusted OR 2.10, 95% CI 1.50–2.94, P<0.0001), and the effect was mediated partly by a reduced prevalence of Trichuris trichiura among treated children. Ivermectin treatments were associated with an increased prevalence of recent eczema symptoms (adjusted OR 2.24, 95% CI 1.05–4.78, P=0.04) but not symptoms of asthma or rhino-conjunctivitis. The effect on eczema symptoms was not associated with reductions in geohelminth infections. Conclusion Long-term periodic treatments with ivermectin were associated with an increased prevalence of allergen skin test reactivity. There was some evidence that treatment was associated with an increased prevalence of recent eczema symptoms but not those of asthma or rhino-conjunctivitis. Cite this as: P. Endara, M. Vaca, M. E. Chico, S. Erazo, G. Oviedo, I. Quinzo, A. Rodriguez R. Lovato, A.-L. Moncayo, M. L. Barreto, L. C. Rodrigues and P. J. Cooper, Clinical & Experimental Allergy, 2010 (40) 1669–1677.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1 Nicolau N, Siddique N, Custovic A. Allergic disease in urban and rural populations: increasing prevalence with increasing urbanization. Allergy 2005; 60:1357-60.
    • 2 Addo-Yobo EO, Woodcock A, Allotey A, Baffoe-Bonnie B, Strachan D, Custovic A. Excercise-induced bronchospasm and atopy in Ghana: two surveys ten years apart. PLoS Med 2007; 4:e70.
    • 3 Bethony J, Brooker S, Albonico M et al. Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet 2006; 367:1521-32.
    • 4 WHO. Deworming for health and development: report of the Third Global Meeting of the Partners for Parasite Control. Geneva: World Health Organization, 2005.
    • 5 Davey G, Venn A, Belete H, Berhane Y, Britton J. Wheeze, allergic sensitization and geohelminth infection in Butajira, Ethiopia. Clin Exp Allergy 2005; 35:301-7.
    • 6 Cooper PJ, Chico ME, Rodrigues LC et al. Reduced risk of atopy among school-age children infected with geohelminth parasites in a rural area of the tropics. J Allergy Clin Immunol 2003; 111:995-1000.
    • 7 Flohr C, Tuyen LN, Lewis S et al. Poor sanitation and helminth infection protect against skin sensitization in Vietnamese children: a cross-sectional study. J Allergy Clin Immunol 2006; 118: 1305-11.
    • 8 Rodrigues LC, Newcombe PJ, SCAALA (Social Change, Asthma and Allergy in Latin America). et al. Early infection with Trichuris trichiura and allergen skin test reactivity in later childhood. Clin Exp Allergy 2008; 381:1769-77.
    • 9 Scrivener S, Yemaneberhan H, Zebenigus M et al. Independent effects of intestinal parasite infection and domestic allergen exposure on risk of wheeze in Ethiopia: a nested case control study. Lancet 2001; 358:1493-9.
    • 10 Lynch NR, Hagel I, Perez M, Di Prisco MC, Lopez R, Alvarez N. Effect of anthelmintic treatment on the allergic reactivity of children in a tropical slum. J Allergy Clin Immunol 1993; 92:404-11.
    • 11 van den Biggelaar AH, Rodrigues LC, van Ree R et al. Long-term treatment of intestinal helminths increases mite skin-test reactivity in Gabonese schoolchildren. J Infect Dis 2004; 189:892-900.
    • 12 Flohr C, Tuyen LN, Quinnell RJ et al. Reduced helminth burden increases allergen skin sensitization but not clinical allergy: a randomized, double-blind, placebo-controlled trial in Vietnam. Clin Exp Allergy 2010; 40:131-42.
    • 13 Cooper PJ, Chico ME, Vaca MG et al. Effect of albendazole treatments on the prevalence of atopy in children living in communities endemic for geohelminth parasites: a cluster-randomised trial. Lancet 2006; 367:1598-603.
    • 14 Vieira JC, Cooper PJ, Lovato R et al. Impact of long-term treatment of onchocerciasis with ivermectin in Ecuador: potential for elimination of infection. BMC Med 2007; 5:9.
    • 15 Ottesen EA, Campbell WC. Ivermectin in human medicine. J Antimicrob Chemother 1994; 34:195-203.
    • 16 Cooper PJ, Chico ME, Vaca MG et al. Risk factors for asthma and allergy associated with urban migration: background and methodology of a cross-sectional study in Afro-Ecuadorian school children in Northeastern Ecuador (Esmeraldas-SCAALA Study). BMC Pulm Med 2006; 6:24.
    • 17 Guderian RH, Shelley AJ. Onchocerciasis in Ecuador: the situation in 1989. Mem Inst Oswaldo Cruz 1992; 87:405-15.
    • 18 Guderian RH, Mackenzie CD, Proa n˜o JR. Onchocerciasis in Ecuador: absence of microfilaraemia. J Trop Med Hyg 1987; 90:213-4.
    • 19 WHO. Diagnostic techniques for intestinal parasitic infections (IPI) applicable to primary health care (PHC) services. Geneva: WHO, 1985.
    • 20 Cooper PJ, Rodrigues LC, Cruz AA, Barreto M. The asthma epidemic in Latin America: a public heath challenge and research opportunities. Allergy 2009; 64:5-17.
    • 21 von Mutius E. Asthma and allergies in rural areas of Europe. Proc Am Thorac Soc 2007; 4:212-6.
    • 22 Elliott AM, Mpairwe H, Quigley MA et al. Helminth infection during pregnancy and development of infantile eczema. JAMA 2005; 294:2032-4.
    • 23 Cooper PJ, Chico ME, Bland M, Griffin GE, Nutman TB. Allergic symptoms, atopy, and geohelminth infections in a rural area of Ecuador. Am J Respir Crit Care Med 2003; 168: 313-7.
    • 24 van den Biggelaar AH, van Ree R, Rodrigues LC et al. Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10. Lancet 2000; 356: 1723-7.
    • 25 Cooper PJ, Mitre E, Moncayo AL, Chico ME, Vaca M, Nutman TB. Ascaris lumbricoides-induced interleukin-10 is not associated with atopy in school children in a rural area of the tropics. J Infect Dis 2008; 197:1333-40.
    • 26 Ponte EV, Lima F, Arau´ jo MI, Oliveira RR, Cardoso LS, Cruz AA. Skin test reactivity and Der p-induced interleukin 10 production in patients with asthma or rhinitis infected with Ascaris. Ann Allergy Asthma Immunol 2006; 96:713-8.
    • 27 Keiser J, Utzinger J. Efficacy of current drugs against soiltransmitted helminth infections: systematic review and metaanalysis. JAMA 2008; 299:1937-48.
    • 28 Ranque S, Chippaux JP, Garcia A, Boussinesq M. Follow-up of Ascaris lumbricoides and Trichuris trichiura infections in children living in a community treated with ivermectin at 3-monthly intervals. Ann Trop Med Parasitol 2001; 95:389-93.
    • 29 Belizario VY, Amarillo ME, de Leon WU, de los Reyes AE, Bugayong MG, Macatangay BJ. A comparison of the efficacy of single doses of albendazole, ivermectin, and diethylcarbamazine alone or in combinations against Ascaris and Trichuris spp. Bull World Health Organ 2003; 81:35-42.
    • 30 Beach MJ, Streit TG, Addiss DG, Prospere R, Roberts JM, Lammie PJ. Assessment of combined ivermectin and albendazole for treatment of intestinal helminth and Wuchereria bancrofti infections in Haitian schoolchildren. Am J Trop Med Hyg 1999; 60: 479-86.
    • 31 Cooper PJ, Barreto ML, Rodrigues LC. Human allergy and geohelminth infections: a review of the literature and a proposed conceptual model to guide the investigation of possible causal associations. Br Med Bull 2006; 79-80:203-18.
    • 32 Pilger D, Heukelbach J, Khakban A, Araujo Oliveira F, Fengler G, Feldmeier H. Household-wide ivermectin treatment for head lice in an impoverished community: randomized observer-blinded controlled trial. Bull WHO 2010; 88:90-6.
    • 33 Cooper PJ, Nutman TB. Onchocerciasis. In: Strickland GT, ed. Hunter's tropical medicine, 8th Edn. Philadelphia: W. B. Saunders Co., 2000; 756-69.
  • No related research data.
  • Discovered through pilot similarity algorithms. Send us your feedback.

    Title Year Similarity

    Clinical and Experimental Allergy

    201082
    82%

Share - Bookmark

Funded by projects

  • WT | The impact of urbanization, ...

Cite this article